{"id":"W4388627499","doi":"10.25251/skin.7.supp.241","title":"Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials","year":2023,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"Bristol-Myers Squibb","keywords":"Medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Psoriasis; Placebo; Clinical endpoint; Apremilast; Clinical trial; Internal medicine; Randomized controlled trial; Tolerability; Adverse effect; Gastroenterology; Dermatology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008589252,0.0001749602,0.0007661364,0.0004014934,0.00005512532,0.000004732276,0.0003628563,0.0001592838,0.0001559168],"category_scores_gemma":[0.002461471,0.00008612783,0.0001095354,0.0004965267,0.0003297474,0.00004441391,0.00003449755,0.0003708861,0.00001646522],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003904472,"about_ca_system_score_gemma":0.00009433217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009505526,"about_ca_topic_score_gemma":0.0001165644,"domain_scores_codex":[0.9956334,0.002769113,0.0010308,0.0001286281,0.000140195,0.0002978974],"domain_scores_gemma":[0.9934704,0.005559613,0.0006262749,0.0002555152,0.0000622656,0.00002587729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.1597775,0.001276953,0.005740736,0.0001251441,0.001906778,0.01107337,0.077103,0.0001214276,0.4949413,0.0009192175,0.07286288,0.1741517],"study_design_scores_gemma":[0.2222398,0.02786207,0.2757035,0.007194477,0.004780856,0.09992779,0.08342546,0.00008154492,0.06611753,0.0168151,0.1942351,0.001616825],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988863,0.006313765,0.000005830953,0.00371282,0.0006278027,0.0002905141,0.00003817626,0.00000728826,0.0001408326],"genre_scores_gemma":[0.9938886,0.005180003,0.00001636917,0.00026091,0.0001358691,0.000005909298,0.000008569813,0.00001379912,0.0004900212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4288238,"threshold_uncertainty_score":0.3512191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03370635970462376,"score_gpt":0.3210922749445532,"score_spread":0.2873859152399295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}